Correction to “Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy”

By sjmartinez • July 29, 2023

Luo L, Wang X, Liao YP, Chang CH, Nel AE. Correction to "Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy". ACS Nano. 2023 Jul 28. doi: 10.1021/acsnano.3c06667. Epub ahead of print. Erratum for: ACS Nano. 2022 Aug 23;16(8):13168-13182. PMID: 37504218.

Tags: Nano Medicine, Publications

Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor

Luo L, Wang X, Liao YP, Xu X, Chang CH, Nel AE. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering[...]

Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy

Liu Q, Chen G, Liu X, Tao L, Fan Y, Xia T. Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy. ACS Nano. 2024 Feb 7. doi: 10.1021/acsnano.3c11647. Epub[...]

Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance

Kusumoputro S, Au C, Lam KH, Park N, Hyun A, Kusumoputro E, Wang X, Xia T. Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance. Nanomaterials[...]